HIF1A and hepatocellular carcinoma: Supporting this notion, studies have demonstrated that suppressing HIF-1α in HCC significantly reduces cell proliferation and invasiveness, highlighting the potential therapeutic benefits of targeting this pathway for therapeutic benefits [132].